Investigation of Catastrophizing of Pain Reported by Parents in JIA Patients

NCT07185750 | Recruiting

• 1 other identifier: SBA 25/530
• Study Type: observational
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

Juvenile idiopathic arthritis (JIA) is the primary rheumatic disease reported to affect the pediatric population. Research suggests that parents' thoughts and feelings about their child's pain, specifically with JIA diagnosis, may influence treatment compliance. Considering that this situation may also affect children's adherence to treatment, the identification and management of parents' catastrophizing of pain is emphasized as important in improving treatment outcomes. This study aimed to examine the biopsychosocial characteristics of parents of children diagnosed with JIA according to their reported catastrophizing of pain.

Conditions

Juvenile Idiopathic Arthritis (JIA); Childhood Rheumatic Diseases

Keywords

Pain catastrophizing; chronic pain

Outcome Measures

Primary Outcomes (2)

• Pain Catastrophizing Scale-Parent (PCS-P)

  It is assessed using a 5-point Likert scale ranging from 0 (never) to 4 (always) and consists of 13 items. Similar to the child questionnaire, it assesses 3 domains: rumination, magnification, and helplessness. A total score between 0 and 52 is obtained; higher scores reflect a higher level of catastrophizing in parents.

  Baseline

• Pain Catastrophizing Scale-Children (PCS-C)

  Consists of 13 items that describe the different thoughts and feelings children may experience when they feel pain. The questionnaire measures three domains: rumination, magnification, and helplessness. All items are rated on a 5-point Likert scale ranging from 0 (never) to 4 (always). Higher scores indicate more catastrophic pain beliefs. The total score ranges from 0 to 52.

  Baseline

Secondary Outcomes (5)

• Juvenile Arthritis Biopsychosocial Scale-JAB-Q-Patient

  Baseline

• Childhood Health Assessment Questionnaire (CHAQ)

  Baseline

• Juvenile Arthritis Quality of Life Questionnaire (JAQQ)

  Baseline

• Juvenile Arthritis Biopsychosocial Scale-JAB-Q-Family

  Baseline

• Child and Adolescent Scale of Participation (CASP)

  Baseline

Study Arms (1)

Cases diagnosed with JIA

JIA patients and their parents who visited the rheumatology outpatient clinic of a university hospital. A questionnaire will be administered to the child cases and their parents.

Other: Questionnaire application for JIA cases and their parents

Interventions

Questionnaire application for JIA cases and their parents OTHER

Scales will be applied to cases diagnosed with JIA and their parents

Cases diagnosed with JIA

Eligibility Criteria

• Age: 7 Years - 18 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Probability Sample

Study Population

The study population will consist of individuals who come to the university hospital for routine controls.

You may qualify if:

• Between 7-18 years of age
• Diagnosed with JIA
• Individuals who volunteer to participate in the study will be included.

You may not qualify if:

• Having advanced heart/lung/liver/kidney disease, neurological disease, or malignancies
• Having undergone major orthopedic surgery
• Not volunteering to participate in the study

Sponsors & Collaborators

• Hacettepe University: lead

Study Sites (1)

Hacettepe University

Çankaya, Ankara, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Arthritis, Juvenile; Chronic Pain

Condition Hierarchy (Ancestors)

Arthritis; Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases; Connective Tissue Diseases; Skin and Connective Tissue Diseases; Autoimmune Diseases; Immune System Diseases; Pain; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Central Study Contacts

Orkun Tüfekçi, PT, PhD(c)

CONTACT

5319502648; orkuntf@gmail.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 5 Days
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator, PT, PhD(c)

Study Record Dates

• First Submitted: September 13, 2025
• First Posted: September 22, 2025
• Study Start: August 4, 2025
• Primary Completion (Estimated): August 4, 2026
• Study Completion (Estimated): August 4, 2027
• Last Updated: September 22, 2025

Record last verified: 2025-08

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)